Adicet Bio, Inc. (ACET)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$39.1M
Cash & Equivalents
$21.5M
Quarterly Burn Rate
5 mo
Est. Cash Runway
$83M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT04911478 Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells OTHER Active Not Recruiting 50

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for ACET.

SEC EDGAR Filings

All SEC filings for Adicet Bio, Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.